Clinical Research Hub
Live Research Database

Migraine
Hub: Ann Arbor, MI

Connecting patients in Ann Arbor with breakthrough clinical trials, specialized care, and study-related compensation.

User
User
User
User
+4k
Join 4,200+ participants tracking trials in Michigan

Available Migraine Opportunities

13 Recruiting
NCT06641466(Verify)

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

RECRUITING
Migraine
NCT04743141(Verify)

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

RECRUITING
Migraine
NCT05711394(Verify)

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

RECRUITING
Migraine
NCT04748601(Verify)

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

RECRUITING
Migraine
NCT05897320(Verify)

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

RECRUITING
Migraine
NCT04649242(Verify)

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

RECRUITING
Migraine
NCT05769348(Verify)

Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)

RECRUITING
Migraine
NCT05164172(Verify)

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

RECRUITING
Migraine
NCT06625060(Verify)

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

RECRUITING
Migraine
NCT06616194(Verify)

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

RECRUITING
Migraine
NCT06810505(Verify)

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

RECRUITING
Migraine
NCT04965675(Verify)

A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

RECRUITING
Migraine
NCT06417775(Verify)

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

RECRUITING
Migraine

Patient Safeguards

IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks

"Advancing Migraine research in Ann Arbor through safe, transparent, and patient-first clinical trials."

Migraine Hubs in MI

Regional Network of Excellence

ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT